Model-based parametric study of frontostriatal abnormalities in schizophrenia patients

BMC Psychiatry

Volumn 10, Issue , 2010, Pages

  Tanaka, Shoji ^a  

^a SOPHIA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE 2 RECEPTOR; NEUROLEPTIC AGENT;

ARTICLE; AUTONOMIC INNERVATION; BRAIN FUNCTION; BRAIN MALFORMATION; BRAIN REGION; CATECHOLAMINE DEPLETION; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC SYSTEM; DRUG RECEPTOR BINDING; FRONTAL CORTEX; HUMAN; MATHEMATICAL MODEL; NEUROTRANSMISSION; OUTCOME ASSESSMENT; PARAMETRIC TEST; POSITIVE SYNDROME; PREDICTION; PREFRONTAL CORTEX; RECEPTOR OCCUPANCY; SCHIZOPHRENIA; STRIATE CORTEX;

EID: 77949363949     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/1471-244X-10-17     Document Type: Article

References (47)

1. Hill K, Mann L, Laws KR, Stephenson CME, Nimmo-Smith I, McKenna PJ. Hypofrontality in schizophrenia: a meta-analysis of functional imaging studies. Acta Psychiatrica Scandinavica 2004, 110(4):243-256. 10.1111/j.1600-0447.2004.00376.x, 15352925.
2. Carter CS, Perlstein P, Ganguli R, Brar J, Mintun M, Cohen JD. Functional hypofrontality and working memory dysfunction in schizophrenia. Am J Psychiatry 1998, 155:1285-1287.
3. Perlstein WM, Carter CS, Noll DC, Cohen JD. Relation of prefrontal cortex dysfunction to working memory and symptoms in schizophrenia. Am J Psychiatry 2001, 158(7):1105-1113. 10.1176/appi.ajp.158.7.1105, 11431233.
4. Riehemann S, Volz HP, Stützer P, Smesny S, Gaser C, Sauer H. Hypofrontality in neuroleptic-naive schizophrenic patients during the Wisconsin Card Sorting Test--a fMRI study. Eur Arch Psychiatry Clin Neurosci 2001, 251(2):66-71. 10.1007/s004060170055, 11407441.
5. Weinberger DR, Berman KF, Zec RF. Physiologic Dysfunction of Dorsolateral Prefrontal Cortex in Schizophrenia: I. Regional Cerebral Blood Flow Evidence. Arch Gen Psychiatry 1986, 43(2):114-124.
6. Wolkin A, Sanfilipo M, Wolf AP, Angrist B, Brodie JD, Rotrosen J. Negative symptoms and hypofrontality in chronic schizophrenia. Arch Gen Psychiatry 1992, 49(12):959-965.
7. Andreasen NC, O'Leary DS, Flaum M, Nopoulos P, Watkins GL, Boles Ponto LL, Hichwa RD. Hypofrontality in schizophrenia: distributed dysfunctional circuits in neuroleptic-naive patients. Lancet 1997, 349(9067):1730-1734. 10.1016/S0140-6736(96)08258-X, 9193383.
8. Whalley HC, Mowatt L, Stanfield AC, Hall J, Johnstone EC, Lawrie SM, McIntosh AM. Hypofrontality in subjects at high genetic risk of schizophrenia with depressive symptoms. Journal of Affective Disorders 2008, 109(1):99-106. 10.1016/j.jad.2007.11.009, 18164074.
9. Park IH, Kim JJ, Chun J, Jung YC, Seok JH, Park HJ, Lee JD. Medial prefrontal default-mode hypoactivity affecting trait physical anhedonia in schizophrenia. Psychiatry Research: Neuroimaging 2009, 171(3):155-165.
10. Morey RA, Inan S, Mitchell TV, Perkins DO, Lieberman JA, Belger A. Imaging frontostriatal function in ultra-high-risk, early, and chronic schizophrenia during executive processing. Arch Gen Psychiatry 2005, 62(3):254-262. 10.1001/archpsyc.62.3.254, 2732718, 15753238.
11. Whalley HC, Simonotto E, Moorhead W, McIntosh A, Marshall I, Ebmeier KP, Owens DG, Goddard NH, Johnstone EC, Lawrie SM. Functional imaging as a predictor of schizophrenia. Biol Psychiatry 2006, 60(5):454-462. 10.1016/j.biopsych.2005.11.013, 16460690.
12. Molina V, Sanz J, Reig S, Martinez R, Sarramea F, Luque R, Benito C, Gispert J, Pascau J, Desco M. Hypofrontality in men with first-episode psychosis. Br J Psychiatry 2005, 186:203-208. 10.1192/bjp.186.3.203, 15738500.
13. Thermenos HW, Goldstein JM, Buka SL, Poldrack RA, Koch JK, Tsuang MT, Seidman LJ. The effect of working memory performance on functional MRI in schizophrenia. Schizophr Res 2005, 74(2-3):179-194. 10.1016/j.schres.2004.07.021, 15721998.
14. Glahn DC, Ragland JD, Abramoff A, Barrett J, Laird AR, Bearden CE, Velligan DI. Beyond hypofrontality: A quantitative meta-analysis of functional neuroimaging studies of working memory in schizophrenia. Hum Brain Mapp 2005, 25(1):60-69. 10.1002/hbm.20138, 15846819.
15. Manoach DS, Press DZ, Thangaraj V, Searl MM, Goff DC, Halpern E, Saper CB, Warach S. Schizophrenic subjects activate dorsolateral prefrontal cortex during a working memory task, as measured by fMRI. Biol Psychiatry 1999, 45:1128-1137. 10.1016/S0006-3223(98)00318-7, 10331104.
16. Tanaka S. Dopaminergic control of working memory and its relevance to schizophrenia: a circuit dynamics perspective. Neuroscience 2006, 139:153-171. 10.1016/j.neuroscience.2005.08.070, 16324800.
17. Manoach DS, Halpern EF, Kramer TS, Chang Y, Goff DC, Rauch SL, Kennedy DN, Gollub RL. Test-retest reliability of a functional MRI working memory paradigm in normal and schizophrenic subjects. Am J Psychiatry 2001, 158(6):955-958. 10.1176/appi.ajp.158.6.955, 11384907.
18. Haroutunian V, Knott P, Davis KL. Effects of mesocortical dopaminergic lesions upon subcortical dopaminergic function. Psychopharmacol Bull 1988, 24(3):341-344.
19. Lipska BK, Weinberger DR. Cortical regulation of the mesolimbic dopamine system: implications for schizophrenia. Limbic motor circuits and neuropsychiatry Ch11 CRC 1993, Kalivas PW, Barnes CD.
20. Meyer-Lindenberg A, Miletich RS, Kohn PD, Esposito G, Carson RE, Quarantelli M, Weinberger DR, Berman KF. Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia. Nat Neurosci 2002, 5(3):267-271. 10.1038/nn804, 11865311.
21. Kolachana BS, Saunders RC, Weinberger DR. Augmentation of prefrontal cortical monoaminergic activity inhibits dopamine release in the caudate nucleus: an in vivo neurochemical assessment in the rhesus monkey. Neuroscience 1995, 69(3):859-868. 10.1016/0306-4522(95)00246-F, 8596654.
22. Abi-Dargham A, Rodenhiser J, Printz D, Zea-Ponce Y, Gil R, Kegeles LS, Weiss R, Cooper TB, Mann JJ, Heertum RLV, et al. Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. Proc Natl Acad Sci USA 2000, 97:8104-8109. [comments in Seeman and Kapur (2000) PNAS PMID: 10884398], 10.1073/pnas.97.14.8104, 16677, 10884434.
23. Agid O, Mamo D, Ginovart N, Vitcu I, Wilson AA, Zipursky RB, Kapur S. Striatal vs extrastriatal dopamine D2 receptors in antipsychotic response--a double-blind PET study in schizophrenia. Neuropsychopharmacology 2007, 32(6):1209-1215. 10.1038/sj.npp.1301242, 17077809.
24. Nicola SM, Surmeier DJ, Malenka RC. Dopaminergic modulation of neuronal excitability in the striatum and nucleus accumbens. Annu Rev Neurosci 2000, 23:185-215. 10.1146/annurev.neuro.23.1.185, 10845063.
25. Surmeier DJ, Song WJ, Yan Z. Coordinated expression of dopamine receptors in neostriatal medium spiny neurons. J Neurosci 1996, 16(20):6579-6591.
26. Bamford NS, Robinson S, Palmiter RD, Joyce JA, Moore C, Meshul CK. Dopamine modulates release from corticostriatal terminals. J Neurosci 2004, 24(43):9541-9552. 10.1523/JNEUROSCI.2891-04.2004, 15509741.
27. Bamford NS, Schmitz Y, Schumauss C, Zakharenko SS, Zablow L, Sulzer D. Heterosynaptic dopamine neurotransmission selects sets of corticostriatal terminals. Neuron 2004, 42(4):653-663. 10.1016/S0896-6273(04)00265-X, 15157425.
28. Meador-Woodruff JH, Damask SP, Watson SJJ. Differential expression of autoreceptors in the ascending dopamine systems of the human brain. Proc Natl Acad Sci USA 1994, 91(17):8297-8301. 10.1073/pnas.91.17.8297, 44593, 7914704.
29. Wang H, Pickel VM. Dopamine D2 receptors are present in prefrontal cortical afferents and their targets in patches of the rat caudate-putamen nucleus. J Comp Neurol 2002, 442:392-404. 10.1002/cne.10086, 11793342.
30. Horvitz JC. Dopamine gating of glutamatergic sensorimotor and incentive motivational input signals to the striatum. Behav Brain Res 2002, 137:65-74. 10.1016/S0166-4328(02)00285-1, 12445716.
31. McGowan S, Lawrence AD, Sales T, Quested D, Grasby P. Presynaptic Dopaminergic Dysfunction in Schizophrenia: A Positron Emission Tomographic [18F] Fluorodopa Study. Arch Gen Psychiatry 2004, 61:134-142. 10.1001/archpsyc.61.2.134, 14757589.
32. Brady AM, O'Donnell P. Dopaminergic modulation of prefrontal cortical input to nucleus accumbens in vivo. Journal of Neuroscience 2004, 24:1040-1049. 10.1523/JNEUROSCI.4178-03.2004, 14762122.
33. Slifstein M, Laruelle M. Models and methods for derivation of in vivo neuroreceptor parameters with PET and SPECT reversible radiotracers. Nucl Med Biol 2001, 28(5):595-608. 10.1016/S0969-8051(01)00214-1, 11516703.
34. Laruelle M, D'Souza CD, Baldwin RM, Abi-Dargham A, Kanes SJ, Fingado CL, Seibyl JP, Zoghbi SS, Bowers MB, Jatlow P, et al. Imaging D2 Receptor Occupancy by Endogenous Dopamine in Humans. Neuropsychopharmacology 1997, 17:162-174. 10.1016/S0893-133X(97)00043-2, 9272483.
35. Erlandsson K, Bressan RA, Mulligan RS, Ell PJ, Cunningham VJ, Pilowsky LS. Analysis of D2 dopamine receptor occupancy with quantitative SPET using the high-affinity ligand [123I] epidepride: resolving conflicting findings. Neuroimage 2003, 19:1205-1214. 10.1016/S1053-8119(03)00166-6, 12880845.
36. Riccardi P, Baldwin R, Salomon R, Anderson S, Ansari MS, Li R, Dawant B, Bauernfeind A, Schmidt D, Kessler R. Estimation of Baseline Dopamine D2 Receptor Occupancy in Striatum and Extrastriatal Regions in Humans with Positron Emission Tomography with [18F] Fallypride. Biological psychiatry 2008, 63(2):241-244. 10.1016/j.biopsych.2007.03.022, 17586476.
37. Verhoeff NP, Kapur S, Hussey D, Lee M, Christensen B, Psych C, Papatheodorou G, Zipursky RB. A simple method to measure baseline occupancy of neostriatal dopamine D2 receptors by dopamine in vivo in healthy subjects. Neuropsychopharmacology 2001, 25(2):213-223. 10.1016/S0893-133X(01)00231-7, 11425505.
38. Voruganti L, Slomka P, Zabel P, Costa G, So A, Mattar A, Awad AG. Subjective effects of AMPT-induced dopamine depletion in schizophrenia: correlation between dysphoric responses and striatal D2 binding ratios on SPECT imaging. Neuropsychopharmacology 2001, 25(5):642-650. 10.1016/S0893-133X(01)00263-9, 11682247.
39. Sesack SR, Carr DB. Selective prefrontal cortex inputs to dopamine cells: implications for schizophrenia. Physiol Behav 2002, 77(4-5):513-517. 10.1016/S0031-9384(02)00931-9, 12526992.
40. Koch K, Wagner G, Nenadic I, Schachtzabel C, Schultz C, Roebel M, Reichenbach JR, Sauer H, Schlosser RGM. Fronto-striatal hypoactivation during correct information retrieval in patients with schizophrenia: An fMRI study. Neuroscience 2008, 153(1):54-62. 10.1016/j.neuroscience.2008.01.063, 18359576.
41. Pantelis C, Barnes TR, Nelson HE, Tanner S, Weatherley L, Owen AM, Robbins T. Frontal-striatal cognitive deficits in patients with chronic schizophrenia. Brain 1997, 120:1823-1843. 10.1093/brain/120.10.1823, 9365373.
42. Robbins TW. The case of frontostriatal dysfunction in schizophrenia. Schizophr Bull 1990, 16(3):391-402.
43. Frankle WG, Gil R, Hackett E, Mawlawi O, Zea-Ponce Y, Zhu Z, Kochan LD, Cangiano C, Slifstein M, Gorman JM, et al. Occupancy of dopamine D2 receptors by the atypical antipsychotic drugs risperidone and olanzapine: theoretical implications. Psychopharmacology (Berl) 2004, 175:473-480.
44. Seeman P, Tallerico T. Rapid release of antipsychotic drugs from dopamine D2 receptors: an explanation for low receptor occupancy and early clinical relapse upon withdrawal of clozapine or quetiapine. Am J Psychiatry 1999, 156(6):876-884.
45. Kapur S, Zipursky R, Jones C, Remington G, Houle S. Relationship Between Dopamine D2 Occupancy, Clinical Response, and Side Effects: A Double-Blind PET Study of First-Episode Schizophrenia. Am J Psychiatry 2000, 157:514-520. 10.1176/appi.ajp.157.4.514, 10739409.
46. Kessler RM, Ansari MS, Riccardi P, Li R, Jayathilake K, Dawant B, Meltzer HY. Occupancy of Striatal and Extrastriatal Dopamine D2 Receptors by Clozapine and Quetiapine. Neuropsychopharmacology 2006, 31(9):1991-2001. 10.1038/sj.npp.1301108, 16738543.
47. Mizrahi R, Rusjan P, Agid O, Graff A, Mamo DC, Zipursky RB, Kapur S. Adverse Subjective Experience With Antipsychotics and Its Relationship to Striatal and Extrastriatal D2 Receptors: a PET Study in Schizophrenia. Am J Psychiatry 2007, 164(4):630-637. 10.1176/appi.ajp.164.4.630, 17403977.